Education
About Us
Working with TipRanks
Follow Us
Lexeo Therapeutics, Inc. (LXEO)
NASDAQ:LXEO
Lexeo Therapeutics, Inc. (LXEO) Ownership Overview
0.86% Insiders
5.40% Mutual Funds
25.26% Other Institutional Investors
12.92% ETFs
55.56% Public Companies and
Individual Investors
The ownership structure of Lexeo Therapeutics, Inc. (LXEO) stock is a mix of institutional, retail, and individual investors. Approximately 43.58% of the company’s stock is owned by Institutional Investors, 0.86% is owned by Insiders, and 55.56% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Nov 20, 2025 | xxxxxxxxxxxxx | $10447 | |
Nov 20, 2025 | xxxxxxxxxxxxx | $3578 | |
Nov 20, 2025 | xxxxxxxxxxxxx | $5089 | |
Nov 20, 2025 | xxxxxxxxxxxxx | $5701 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,396,856 | Institution | 4.65% | 25,102,766 | |
| 2,888,715 | Institution | 3.96% | 21,347,604 | |
| 2,572,162 | Institution | 3.52% | 19,008,277 | |
| 2,184,779 | Institution | 2.99% | 16,145,517 | |
| 1,799,143 | Institution | 2.47% | 13,295,667 | |
| 1,184,636 | Institution | 1.62% | 8,754,460 | |
| 1,124,922 | Institution | 1.54% | 8,313,174 | |
| 978,652 | Institution | 1.34% | 7,232,238 | |
| 642,299 | Institution | 0.88% | 4,746,590 | |
| 546,554 | Institution | 0.75% | 4,039,034 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,799,143 | Institution | 2.47% | 13,295,667 | |
| 642,299 | Institution | 0.88% | 4,746,590 | |
| 511,415 | Institution | 0.70% | 3,779,357 | |
| 279,871 | Institution | 0.38% | 2,068,247 | |
| 236,388 | Institution | 0.32% | 1,746,907 | |
| 129,065 | Institution | 0.18% | 953,790 | |
| 83,361 | Institution | 0.11% | 616,038 | |
| 70,411 | Institution | 0.10% | 520,337 | |
| 45,000 | Institution | 0.06% | 332,550 | |
| 31,235 | Institution | 0.04% | 230,827 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,259,260 | Institution | 3.10% | 22,434,452 | |
| 1,766,938 | Institution | 2.42% | 13,252,035 | |
| 1,524,402 | Institution | 2.09% | 11,433,015 | |
| 641,993 | Institution | 0.88% | 6,374,990 | |
| 536,240 | Institution | 0.73% | 4,021,800 | |
| 447,107 | Institution | 0.61% | 3,353,303 | |
| 346,034 | Institution | 0.47% | 2,595,255 | |
| 320,408 | Institution | 0.44% | 2,403,060 | |
| 309,793 | Institution | 0.42% | 3,076,244 | |
| 160,443 | Institution | 0.22% | 1,203,323 |
FAQ
Who Owns Lexeo Therapeutics, Inc. (LXEO)?
According to the latest TipRanks data, approximately 25.26% of the company's stock is held by institutional investors, 0.86% is held by insiders, and 55.56% is held by retail investors.
What percentage of Lexeo Therapeutics, Inc. (LXEO) stock is held by institutional investors?
According to the latest TipRanks data, approximately 25.26% of Lexeo Therapeutics, Inc. (LXEO) stock is held by institutional investors.
What percentage of Lexeo Therapeutics, Inc. (LXEO) stock is held by retail investors?
According to the latest TipRanks data, approximately 55.56% of Lexeo Therapeutics, Inc. (LXEO) stock is held by retail investors.
Who owns the most shares of Lexeo Therapeutics, Inc. (LXEO)?
Vanguard owns the most shares of Lexeo Therapeutics, Inc. (LXEO).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.